Successful Prasugrel Rescue Therapy in Clopidogrel Resistant Patients Who Had Recurrent Stent Thrombosis of Drug-Eluting-Stent: The Role of Prasugrel in Clopidogrel Nonresponders.
10.4070/kcj.2013.43.5.343
- Author:
Seung Hyun LEE
1
;
Byeong Keuk KIM
;
Jaewon OH
;
Jin Su PARK
;
Dong Jun LEE
;
Han Cheol LEE
;
Jin Ho KIM
;
Myeong Ki HONG
Author Information
1. Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea. mkhong61@yuhs.ac
- Publication Type:Case Report
- Keywords:
Drug-eluting stents;
Thrombosis;
Clopidogrel;
Prasugrel
- MeSH:
Drug-Eluting Stents;
Humans;
Incidence;
Male;
Piperazines;
Stents;
Thiophenes;
Thrombosis;
Ticlopidine;
Prasugrel Hydrochloride
- From:Korean Circulation Journal
2013;43(5):343-346
- CountryRepublic of Korea
- Language:English
-
Abstract:
Stent thrombosis is a very serious problem after drug-eluting stent (DES) implantation even though its incidence is about or less than 1%. As the clopidogrel resistance is expected to play an important role in the occurrence of stent thrombosis, new anti-platelet agents overcoming this issue can give us another choice. We experienced a case of a 58-year-old male with successful prasugrel rescue therapy in a patient with clopidogrel resistance who had recurrent stent thrombosis following DES implantation.
